0

Close
 
2022
Interventional Cardiology And Peripheral Vascular Devices Market

Interventional Cardiology and Peripheral Vascular Devices Market

by Type (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories), by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
Update Available On-Demand

LS : Medical Devices & Supplies
✷  Report Code: A00917
Mar 2022 | Pages: 205
Tables: 120
Charts: 56

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

Interventional Cardiology And Peripheral Vascular Devices Market Research, 2030

The global interventional cardiology and peripheral vascular devices market size was valued at $17,960.8 million in 2020, and is projected to reach $41,900.3 million by 2030, growing at a CAGR of 8.5% from 2021 to 2030. Interventional cardiology deals with the catheter-based approach for the treatment of structural heart diseases. If a catheter-based approach is used in the region of arms or legs, then it is included under peripheral vascular devices.

The interventional cardiology and peripheral vascular devices market has been negatively impacted by COVID-19, due to lockdown in several countries globally.

The demand for healthcare services has significantly increased in the past few years owing to rise in global population. Furthermore, the number of patients suffering from cardiological and vascular diseases has consistently increased owing to surge in geriatric population. This has fueled the demand for devices used in treatment of cardiological and vascular diseases. Furthermore, interventional cardiology and peripheral vascular devices can be used for treatment of various heart and artery ailments. Also, advancements in technology have positively influenced the interventional cardiology and peripheral vascular devices market share. In addition, the rapid growth of healthcare industry in developing countries, positively influence the interventional cardiology and peripheral vascular devices market growth. 

According to U.S. Department of Health & Human Services, heart diseases are a leading cause of death in U.S., as 1 in every 4 deaths is associated with heart diseases. Furthermore, Coronary heart disease is the most common type of heart disease in U.S. that killed 360,900 people in 2019.Furthermore, according to Centers for Disease Control and Prevention, an entity of U.S. Department of Health & Human Services, as of 2021, 6 in every 10 U.S. adults have a chronic disease and 4 in every 10 U.S. adults have two or more chronic diseases. This significantly increases the use of interventional cardiology and peripheral vascular devices for treatment of cardiovascular diseases. Furthermore, the healthcare infrastructure in developing countries has expanded rapidly. For instance, according to India Brand Equity Foundation, by 2022, the Indian healthcare infrastructure is expected to reach a value of US$ 349.1 billion and by 2025.

Interventional Cardiology and Peripheral Vascular Devices Market

The novel coronavirus has rapidly spread across various countries and regions, causing an enormous impact on the lives of people and the overall community. It began as a human health condition and has now become a significant threat to global trade, economy, and finance. The COVID-19 pandemic has increased the highlighted the importance of government healthcare facilities, thereby increasing healthcare spendings across the globe. Furthermore, the number of COVID-19 cases is expected to reduce in the near future as the vaccine for COVID-19 is introduced in the market. This has led to the reopening of interventional cardiology and peripheral vascular devices manufacturing facilities at their full-scale capacities. This is expected to help the interventional cardiology market to recover by the start of 2022. After COVID-19 infection cases begin to decline, companies involved in manufacturing of interventional cardiology and peripheral vascular devices must focus on protecting their staff, operations, and supply networks to respond to urgent emergencies and establish new methods of working.

Furthermore, the capabilities of interventional cardiology and peripheral vascular devices to effectively treat cardiovascular ailments propel the growth of the interventional cardiology market. Also, increasing awareness among masses regarding various medical treatments positively influences the market. In addition, the advancements in healthcare facilities of developing countries is one of the major interventional cardiology and peripheral vascular devices market opportunities.

Interventional Cardiology and Peripheral Vascular Devices Market

The interventional cardiology and peripheral vascular devices market is segmented on the basis of product, end user, and region. By product, the market is categorized into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. By end user, it is segmented into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in population and rise in spending of healthcare facilities.

Interventional Cardiology and Peripheral Vascular Devices Market

Competition Analysis

Key companies profiled in the interventional cardiology and peripheral vascular devices market report include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc., and Terumo Corporation.

Key Benefits for Stakeholders

  • The report provides an extensive analysis of the current and emerging interventional cardiology and peripheral vascular devices market trends and dynamics. 
  • In-depth interventional cardiology and peripheral vascular devices market size analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
  • Extensive analysis of the interventional cardiology and peripheral vascular devices market size is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • A comprehensive interventional cardiology and peripheral vascular devices market analysis of all the regions is provided to determine the prevailing opportunities.
  • The global interventional cardiology and peripheral vascular devices market forecast analysis from 2021 to 2030 is included in the report.
  • The key players within interventional cardiology and peripheral vascular devices industry are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the interventional cardiology and peripheral vascular devices industry.

 Interventional Cardiology and Peripheral Vascular Devices Market Report Highlights

Aspects Details
By Type
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Accessories
  • Angioplasty Balloons
  • Angioplasty Stents
  • Angioplasty Catheters
  • Endovascular Aneurysm Repair Stent Grafts
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, Rest Of Asia Pacific)
  • LAMEA  (Latin America, Middle East, Africa)
Key Market Players Abbott Laboratories, B. Braun Melsungen AG, Medtronic plc, Becton, Dickinson and Company., Koninklijke Philips N.V., Cook Group, Boston Scientific Corporation, Cardinal Health Inc., Terumo Group, Biotronik SE & Co. KG
 

  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Angioplasty Balloons

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Angioplasty Stents

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Angioplasty Catheters

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Endovascular Aneurysm Repair Stent Grafts

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Inferior Vena Cava (IVC) Filters

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

    • 4.7 Plaque Modification Devices

      • 4.7.1 Key market trends, growth factors and opportunities

      • 4.7.2 Market size and forecast, by region

      • 4.7.3 Market analysis by country

    • 4.8 Hemodynamic Flow Alteration Devices

      • 4.8.1 Key market trends, growth factors and opportunities

      • 4.8.2 Market size and forecast, by region

      • 4.8.3 Market analysis by country

    • 4.9 Accessories

      • 4.9.1 Key market trends, growth factors and opportunities

      • 4.9.2 Market size and forecast, by region

      • 4.9.3 Market analysis by country

  • CHAPTER 5: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Ambulatory Surgical Centers

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Others

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

  • CHAPTER 6: INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Type

      • 6.2.3 North America Market size and forecast, by End User

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Type
          • 6.2.4.1.2 Market size and forecast, by End User
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Type
          • 6.2.4.2.2 Market size and forecast, by End User
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Type
          • 6.2.4.3.2 Market size and forecast, by End User

    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Type

      • 6.3.3 Europe Market size and forecast, by End User

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Type
          • 6.3.4.1.2 Market size and forecast, by End User
        • 6.3.4.2 France
          • 6.3.4.2.1 Market size and forecast, by Type
          • 6.3.4.2.2 Market size and forecast, by End User
        • 6.3.4.3 U.K.
          • 6.3.4.3.1 Market size and forecast, by Type
          • 6.3.4.3.2 Market size and forecast, by End User
        • 6.3.4.4 Spain
          • 6.3.4.4.1 Market size and forecast, by Type
          • 6.3.4.4.2 Market size and forecast, by End User
        • 6.3.4.5 Rest of Europe
          • 6.3.4.5.1 Market size and forecast, by Type
          • 6.3.4.5.2 Market size and forecast, by End User

    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Type

      • 6.4.3 Asia-Pacific Market size and forecast, by End User

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 China
          • 6.4.4.1.1 Market size and forecast, by Type
          • 6.4.4.1.2 Market size and forecast, by End User
        • 6.4.4.2 Japan
          • 6.4.4.2.1 Market size and forecast, by Type
          • 6.4.4.2.2 Market size and forecast, by End User
        • 6.4.4.3 India
          • 6.4.4.3.1 Market size and forecast, by Type
          • 6.4.4.3.2 Market size and forecast, by End User
        • 6.4.4.4 Australia
          • 6.4.4.4.1 Market size and forecast, by Type
          • 6.4.4.4.2 Market size and forecast, by End User
        • 6.4.4.5 Rest Of Asia Pacific
          • 6.4.4.5.1 Market size and forecast, by Type
          • 6.4.4.5.2 Market size and forecast, by End User

    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Type

      • 6.5.3 LAMEA Market size and forecast, by End User

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Latin America
          • 6.5.4.1.1 Market size and forecast, by Type
          • 6.5.4.1.2 Market size and forecast, by End User
        • 6.5.4.2 Middle East
          • 6.5.4.2.1 Market size and forecast, by Type
          • 6.5.4.2.2 Market size and forecast, by End User
        • 6.5.4.3 Africa
          • 6.5.4.3.1 Market size and forecast, by Type
          • 6.5.4.3.2 Market size and forecast, by End User

  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Abbott Laboratories

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 B. Braun Melsungen AG

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Boston Scientific Corporation

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Becton, Dickinson and Company.

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Cardinal Health Inc.

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Cook Group

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Medtronic plc

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Terumo Group

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Koninklijke Philips N.V.

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Biotronik SE & Co. KG

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 2. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY BALLOONS, BY REGION , 2020-2030,($MILLION)
    TABLE 3. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY BALLOONS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 4. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY STENTS, BY REGION , 2020-2030,($MILLION)
    TABLE 5. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY STENTS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 6. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ANGIOPLASTY CATHETERS, BY REGION , 2020-2030,($MILLION)
    TABLE 7. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ANGIOPLASTY CATHETERS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 8. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS, BY REGION , 2020-2030,($MILLION)
    TABLE 9. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 10. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR INFERIOR VENA CAVA (IVC) FILTERS, BY REGION , 2020-2030,($MILLION)
    TABLE 11. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET INFERIOR VENA CAVA (IVC) FILTERS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 12. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR PLAQUE MODIFICATION DEVICES, BY REGION , 2020-2030,($MILLION)
    TABLE 13. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET PLAQUE MODIFICATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
    TABLE 14. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION , 2020-2030,($MILLION)
    TABLE 15. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET HEMODYNAMIC FLOW ALTERATION DEVICES BY COUNTRY, 2020-2030,($MILLION)
    TABLE 16. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR ACCESSORIES, BY REGION , 2020-2030,($MILLION)
    TABLE 17. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET ACCESSORIES BY COUNTRY, 2020-2030,($MILLION)
    TABLE 18. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 19. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
    TABLE 20. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 21. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)
    TABLE 22. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 23. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
    TABLE 24. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
    TABLE 25. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
    TABLE 26. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 27. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 28. NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 29. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 30. U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 31. CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 32. CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 33. MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 34. MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 35. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 36. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 37. EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 38. GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 39. GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 40. FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 41. FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 42. U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 43. U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 44. SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 45. SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 46. REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 47. REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 48. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 49. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 50. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 51. CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 52. CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 53. JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 54. JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 55. INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 56. INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 57. AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 58. AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 59. REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 60. REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 61. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2030,($MILLION)
    TABLE 62. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2030,($MILLION)
    TABLE 63. LAMEA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
    TABLE 64. LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 65. LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 66. MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 67. MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 68. AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY TYPE 2020-2030,($MILLION)
    TABLE 69. AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY END USER 2020-2030,($MILLION)
    TABLE 70.ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 71.ABBOTT LABORATORIES: OPERATING SEGMENTS
    TABLE 72.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
    TABLE 73.ABBOTT LABORATORIES: NET SALES,
    TABLE 74.ABBOTT LABORATORIES: KEY STRATERGIES
    TABLE 75.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    TABLE 76.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
    TABLE 77.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
    TABLE 78.B. BRAUN MELSUNGEN AG: NET SALES,
    TABLE 79.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
    TABLE 80.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 81.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 82.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 83.BOSTON SCIENTIFIC CORPORATION: NET SALES,
    TABLE 84.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 85.BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT
    TABLE 86.BECTON, DICKINSON AND COMPANY.: OPERATING SEGMENTS
    TABLE 87.BECTON, DICKINSON AND COMPANY.: PRODUCT PORTFOLIO
    TABLE 88.BECTON, DICKINSON AND COMPANY.: NET SALES,
    TABLE 89.BECTON, DICKINSON AND COMPANY.: KEY STRATERGIES
    TABLE 90.CARDINAL HEALTH INC.: COMPANY SNAPSHOT
    TABLE 91.CARDINAL HEALTH INC.: OPERATING SEGMENTS
    TABLE 92.CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
    TABLE 93.CARDINAL HEALTH INC.: NET SALES,
    TABLE 94.CARDINAL HEALTH INC.: KEY STRATERGIES
    TABLE 95.COOK GROUP: COMPANY SNAPSHOT
    TABLE 96.COOK GROUP: OPERATING SEGMENTS
    TABLE 97.COOK GROUP: PRODUCT PORTFOLIO
    TABLE 98.COOK GROUP: NET SALES,
    TABLE 99.COOK GROUP: KEY STRATERGIES
    TABLE 100.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 101.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 102.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 103.MEDTRONIC PLC: NET SALES,
    TABLE 104.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 105.TERUMO GROUP: COMPANY SNAPSHOT
    TABLE 106.TERUMO GROUP: OPERATING SEGMENTS
    TABLE 107.TERUMO GROUP: PRODUCT PORTFOLIO
    TABLE 108.TERUMO GROUP: NET SALES,
    TABLE 109.TERUMO GROUP: KEY STRATERGIES
    TABLE 110.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
    TABLE 111.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
    TABLE 112.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
    TABLE 113.KONINKLIJKE PHILIPS N.V.: NET SALES,
    TABLE 114.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
    TABLE 115.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
    TABLE 116.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
    TABLE 117.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
    TABLE 118.BIOTRONIK SE & CO. KG: NET SALES,
    TABLE 119.BIOTRONIK SE & CO. KG: KEY STRATERGIES

  • LIST OF FIGURES

  • FIGURE 1.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
    FIGURE 2.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030
    FIGURE 3.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,BY TYPE,2020(%)
    FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY BALLOONS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY STENTS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ANGIOPLASTY CATHETERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF INFERIOR VENA CAVA (IVC) FILTERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PLAQUE MODIFICATION DEVICES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HEMODYNAMIC FLOW ALTERATION DEVICES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 20.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,BY END USER,2020(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030(%)
    FIGURE 24.INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET BY REGION,2020
    FIGURE 25.U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 26.CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 27.MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 28.GERMANY INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 29.FRANCE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 30.U.K. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 31.SPAIN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 32.REST OF EUROPE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 33.CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 34.JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 35.INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 36.AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 37.REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 38.LATIN AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 39.MIDDLE EAST INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 40.AFRICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET,2020-2030($MILLION)
    FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 45.COMPETITIVE DASHBOARD
    FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 47.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 48.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
    FIGURE 49.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 50.BECTON, DICKINSON AND COMPANY..: NET SALES ,($MILLION)
    FIGURE 51.CARDINAL HEALTH INC..: NET SALES ,($MILLION)
    FIGURE 52.COOK GROUP.: NET SALES ,($MILLION)
    FIGURE 53.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 54.TERUMO GROUP.: NET SALES ,($MILLION)
    FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
    FIGURE 56.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)

 
 

The interventional cardiology and peripheral vascular devices market has witnessed significant growth in past few years owing to rapid growth of healthcare infrastructure across the globe and increased spending on healthcare facilities in developing countries.

The rise in global population has created a demand for healthcare facilities across the globe. Surge in number of patients suffering from various cardiovascular diseases has fueled the use of interventional cardiology and peripheral vascular devices. Furthermore, technological advancements have significantly enhanced the effectiveness of interventional cardiology and peripheral vascular devices in treatment of a wide range of heart and artery disorders. Moreover, increased awareness among masses has resulted in regular health checkups and has positively influenced the industry.

Moreover, supportive government initiatives and rapid growth of healthcare infrastructure in emerging countries provide lucrative growth opportunities for the interventional cardiology and peripheral vascular devices market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Abbott Laboratories, Biotronik SE & Co. KG and Koninklijke Philips N.V. are some of the top companies to hold the market share in interventional cardiology and peripheral vascular devices.

A. In 2020, $17,960.8 million is the estimated industry size of interventional cardiology and peripheral vascular devices.

A. North America is the largest regional market for interventional cardiology and peripheral vascular devices.

A. The company profile has been selected on factors such as geographical presence, market dominance (in terms of revenue and volume sales), various strategies and recent developments.

A. Product launch is key growth strategy of interventional cardiology and peripheral vascular devices industry players.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Interventional Cardiology And Peripheral Vascular Devices Market

Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,565
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Data Pack
  • $3,961
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Single User
  • $5,540
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)
  • Five Users
  • $6,654
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)

  • Enterprise
    License/PDF

  • $10,280
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2023 - Mar 2024)

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers